Should you buy AMLX stock?
Last updated:
Based on market data through , StockInvest.us rates Amylyx Pharmaceuticals, Inc. (AMLX) as a Buy Candidate with a technical score of 3.53 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.
- Buy signal since
- Price since signal Up 55.38%
- 3-month trend forecast Up 56.49%
- +189.9% price growth over the last year
- Lower volatility than the market (beta -0.20)
- +98.5% YTD performance
Amylyx Pharmaceuticals, Inc. stock price ended at $22.67 on Monday, after losing 0.657%
(Market data through Aug 10, 2026)
The Amylyx Pharmaceuticals, Inc. stock price fell by -0.657% on the last day (Monday, 10th Aug 2026) from $22.82 to $22.67. During the last trading day the stock fluctuated 4.64% from a day low at $22.00 to a day high of $23.02. The price has been going up and down for this period, and there has been a 16.32% gain for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -1 million shares and in total, 1 million shares were bought and sold for approximately $29.17 million.
The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 56.49% during the next 3 months and, with a 90% probability hold a price between $29.95 and $38.30 at the end of this 3-month period.
AMLX Signals & Forecast
The Amylyx Pharmaceuticals, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $21.98 and $18.83. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, August 06, 2026, and so far it has fallen -6.28%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Support, Risk & Stop-loss for Amylyx Pharmaceuticals, Inc. stock
On the downside, the stock finds support just below today's level from accumulated volume at $20.75 and $17.79. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Amylyx Pharmaceuticals, Inc. finds support just below today's level at $20.75. If this is broken, then the next support from accumulated volume will be at $17.79 and $17.44.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.02 between high and low, or 4.64%. For the last week, the stock has had daily average volatility of 8.36%.
Our recommended stop-loss: $21.40 (-5.60%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 2 days ago.)
Trading Expectations (AMLX) For The Upcoming Trading Day Of Tuesday 11th
For the upcoming trading day on Tuesday, 11th we expect Amylyx Pharmaceuticals, Inc. to open at $22.56, and during the day (based on 14 day Average True Range), to move between $21.99 and $23.35, which gives a possible trading interval of +/-$1.35 (+/-6.15%) up or down from last closing price. If Amylyx Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 6.15% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $22.82 (0.66%) than the support at $20.75 (8.47%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Amylyx Pharmaceuticals, Inc. stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Amylyx Pharmaceuticals, Inc. stock to perform well in the short-term.
Current score:
3.525
Buy Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on August 11, 2026 - $22.56 ( 0.471%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
AMLX Performance
Trading levels for AMLX
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 23.58 | 4.03% |
| R2 | 23.19 | 2.31% |
| R1 | 22.95 | 1.25% |
| Price | 22.67 | |
| S1 | 22.17 | -2.19% |
| S2 | 21.93 | -3.25% |
| S3 | 21.54 | -4.97% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0 | - |
| R2 | 24.19 | 6.70% |
| R1 | 22.82 | 0.662% |
| Price | 22.67 | |
| S1 | 20.75 | -8.47% |
| S2 | 17.79 | -21.53% |
| S3 | 17.44 | -23.07% |
AMLX Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Jan 25, 2018 | Mar 28, 2018 | Apr 02, 2018 | $0.420 | 0% |
| 2 | Dec 28, 2017 | Dec 28, 2017 | Jan 02, 2018 | $0.360 | 0% |
| 3 | Sep 28, 2017 | Sep 28, 2017 | Oct 02, 2017 | $0.240 | 0% |
FAQ
Click here for our free guide on how to buy Amylyx Pharmaceuticals, Inc. Stock.
Buy AMLX